| Financial Year |
March 31 2023 |
| Monetary Funds |
1,505,773,677.46 |
| Held-for-trading Financial Assets |
100,000,000.00 |
| Notes Receivable |
44,665,325.45 |
| Accounts Receivable |
2,786,890,908.63 |
| Advances to Suppliers |
1,200,344,804.00 |
| Other Receivables |
205,044,788.91 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,472,013,907.23 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
341,540,243.24 |
| Total Current Assets |
7,674,738,502.09 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
157,392,740.15 |
| Investment Properties |
95,938,994.63 |
| Fixed Assetes |
219,792,937.48 |
| Under-construction Projects |
799,656,098.30 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
399,808,103.65 |
| R&D expenses |
120,250,419.37 |
| Goodwill |
328,701,549.88 |
| Long-Term Deferred and Prepaid Expenses |
66,629,792.27 |
| Deferred Income Tax Assets |
61,522,038.26 |
| Other Non-Current Assets |
80,004,727.79 |
| Sub-Total of Non-Current Assets |
2,735,978,129.44 |
| Total Assets |
10,410,716,631.53 |
| Short-Term Loans |
1,256,429,477.90 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,000,982,890.73 |
| Accounts Payable |
1,143,489,972.92 |
| Accounts Received In Advance |
180,000.00 |
| Employee Compensation Payable |
19,472,150.55 |
| Taxes Payable |
12,121,820.62 |
| Interest Payable |
-- |
| Dividend Payable |
228,075.97 |
| Other payables |
781,144,784.92 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
235,233,759.44 |
| Other Current Liabilities |
66,824,425.96 |
| Sub-Total of Current Liabilities |
5,057,278,934.89 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
87,207,882.47 |
| Special Payable |
-- |
| Estimatied Liabilities |
4,591,222.76 |
| Deferred Income Tax Liabilities |
3,012,983.47 |
| Other Non-Current Liabilities |
133,269,481.39 |
| Sub-Total of Non-Current Liabilities |
334,450,761.74 |
| Total Liabilities |
5,391,729,696.63 |
| Paid-In Capital(Or Share Stock) |
1,157,860,020.00 |
| Capital Surplus |
2,930,868,935.67 |
| Surplus Reserve |
58,114,971.95 |
| LESS:Treasury Stock |
83,553,600.00 |
| Undistributed Profits |
402,709,841.91 |
| Minority Stockholder's Interest |
553,241,486.21 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,465,745,448.69 |
| Owner's Equity（Stockholder's Equity） |
5,018,986,934.90 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
10,410,716,631.53 |
